Clinical Trial Update: Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase II trial evaluating a combination of temsirolimus and sorafenib in advanced hepatocellular carcinoma has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: University of California, San Francisco | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-12-07